Honeywell Case Studies Well-Monitored: Diabetes Product Provider Deploys 100,000 Devices in 18 Months

Edit This Case Study Record

	Well-Monitored: Diabetes Product Provider Deploys 100,000 Devices in 18 Months Honeywell

Well-Monitored: Diabetes Product Provider Deploys 100,000 Devices in 18 Months

Honeywell

Technology Category	Networks & Connectivity - Cellular Analytics & Modeling - Machine Learning
Applicable Industries	Healthcare & Hospitals
Use Cases	Remote Patient Monitoring Machine Condition Monitoring
Services	System Integration
Challenge	The global healthcare device manufacturer faced the challenge of quickly filling thousands of pre-release orders for a newly approved glucose monitoring device. Additionally, they needed to prepare for the successful deployment of future healthcare devices by establishing a partnership with an experienced managed mobility services provider. The company was experiencing overwhelming success and needed to ensure that they could meet the high customer demand for their new diabetes monitoring device. Read More
About Customer	The customer is a global healthcare device manufacturer specializing in helping people manage chronic conditions, particularly diabetes. They produce devices that transmit glucose levels and other pertinent information in real time to a network of providers. The company has a significant presence in the healthcare market and aims to expand its product offerings and services. With a focus on innovation and customer satisfaction, the company is dedicated to improving the quality of life for individuals with chronic conditions through advanced medical devices. Read More
Solution	To address the overwhelming success and high demand for their new diabetes monitoring device, the company engaged Honeywell to deploy a two-way, cellular-connected handheld blood glucose meter. This device falls into the growing category of machine-to-machine (M2M) products, which are networked devices that communicate without human intervention, often as part of remote monitoring. Honeywell, with its extensive experience in M2M, leveraged its wide-ranging product expertise to deploy 100,000 devices. This partnership allowed the healthcare device manufacturer to quickly and efficiently meet the pre-release and new orders for their glucose monitoring device. Read More Log in to view content
Contents

Technology Category

Networks & Connectivity - Cellular

Analytics & Modeling - Machine Learning

Applicable Industries

Healthcare & Hospitals

Use Cases

Remote Patient Monitoring

Machine Condition Monitoring

Services

System Integration

Challenge

The global healthcare device manufacturer faced the challenge of quickly filling thousands of pre-release orders for a newly approved glucose monitoring device. Additionally, they needed to prepare for the successful deployment of future healthcare devices by establishing a partnership with an experienced managed mobility services provider. The company was experiencing overwhelming success and needed to ensure that they could meet the high customer demand for their new diabetes monitoring device.

About Customer

The customer is a global healthcare device manufacturer specializing in helping people manage chronic conditions, particularly diabetes. They produce devices that transmit glucose levels and other pertinent information in real time to a network of providers. The company has a significant presence in the healthcare market and aims to expand its product offerings and services. With a focus on innovation and customer satisfaction, the company is dedicated to improving the quality of life for individuals with chronic conditions through advanced medical devices.

Solution

To address the overwhelming success and high demand for their new diabetes monitoring device, the company engaged Honeywell to deploy a two-way, cellular-connected handheld blood glucose meter. This device falls into the growing category of machine-to-machine (M2M) products, which are networked devices that communicate without human intervention, often as part of remote monitoring. Honeywell, with its extensive experience in M2M, leveraged its wide-ranging product expertise to deploy 100,000 devices. This partnership allowed the healthcare device manufacturer to quickly and efficiently meet the pre-release and new orders for their glucose monitoring device.

Impact #1	The company has established an almost immediate and significant foothold in the $250 billion diabetes-management market.
Impact #2	With the successful launch of its product, the company gains funds for anticipated new products and expansion of services.
Impact #3	It has established a relationship with a reliable managed mobility services provider that will help the company rapidly deploy new devices in the future.

Impact #1

The company has established an almost immediate and significant foothold in the $250 billion diabetes-management market.

Impact #2

With the successful launch of its product, the company gains funds for anticipated new products and expansion of services.

Impact #3

It has established a relationship with a reliable managed mobility services provider that will help the company rapidly deploy new devices in the future.

Benefit #1	Deployed 100,000 devices in 18 months.

Benefit #1

Deployed 100,000 devices in 18 months.

Download PDF Version

Overview

Well-Monitored: Diabetes Product Provider Deploys 100,000 Devices in 18 Months

Operational Impact

Quantitative Benefit